Facebook
Twitter
LinkedIn
Forward| Title | Category | Credit | Event date | List Price | |
|---|---|---|---|---|---|
| Incorporating Genomic Testing and Advanced Imaging for Prostate Cancer Into Your Practice Webcast (2025) |
| $0.00 | There are multiple genomic tests and advanced imaging modalities (MRI, PSMA PET, etc) currently available for men to detect and risk stratify prostate cancer. The outcomes of these tests may lead to different detection strategies (observation, immediate biopsy, etc) and treatment decisions (active surveillance, surgery, radiation, adjuvant therapy, etc). We will also discuss germline testing as inherited mutations have considerable implications for screening, treatment, genetic counseling, and cascade testing of family members. | ||
| Institute for Leadership & Business (ILB) Track On-Demand (2023) | $470.00 | Invest in your leadership and business skills with the Institute for Leadership & Business (ILB) Track On-Demand. The ILB Track features 15 hours of programming that will enhance your business skills, activate your interest in business and finance, and inspire the leader in you! | |||
| Institute for Leadership & Business (ILB) Track On-Demand (2024) | $350.00 | NOW OVER 50% OFF - REGISTER TODAY!(Discount automatically applied at checkout for AUA members, residents, and fellows) | |||
| Integration of Biomarkers, MRI and PSMA PET Imaging Into the Management of Prostate Cancer Webcast (2025) |
| $0.00 | |||
| Live From AUA2024: Highlights in Bladder Cancer (2024) |
| $0.00 | Live from AUA2024: Highlights in Bladder Cancer will discuss the best in Bladder Cancer from the 2024 AUA Annual Meeting! | ||
| Live from AUA2025: Advances in ADT (2025) |
| $0.00 | Live from AUA2025: Advances in ADT will discuss the best in the latest advancements in androgen deprivation therapy (ADT) from the AUA Annual Meeting! | ||
| Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems Webcast (2025) |
| $0.00 | This course will focus on specific topics discussed in the recent/amended AUA practice guidelines for non muscle-invasive bladder cancer (NMIBC) and detail strategies to manage common clinical predicaments involved in the management of these tumors. The course will include short didactic lectures by each of the faculty but will focus predominantly on case presentations highlighting common and often perplexing topics in NMIBC. | ||
| Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems Webcast (2024) |
| $0.00 | This course will focus on specific topics discussed in the recent AUA Practice Guidelines for non-muscle invasive bladder cancer (NMIBC) and detail strategies to manage common clinical predicaments involved in the management of these tumors. The course will include short didactic lectures by each of the faculty but will focus predominantly on case presentations highlighting common and often perplexing topics in NMIBC. | ||
| New AUA Guideline (2024): Salvage Therapy for Prostate Cancer Webcast (2024) |
| $0.00 | The course details the 2024 AUA Guidelines for salvage therapy following initial treatment of localized prostate cancer, focusing on integral aspects of salvage treatments, risk stratification and advanced imaging. Participants will gain insights into the timing and appropriate use of salvage radiation therapy with or without androgen deprivation therapy (ADT), the use of risk stratification tools and the application of next-generation imaging in patients with biochemical recurrence. | ||
| Non-Muscle Invasive Bladder Cancer Treatment Dilemmas: The Cases You Face and How Best to Treat Them Webcast (2025) |
| $0.00 | The course will highlight recent updates to AUA, European Association of Urology, and National Comprehensive Cancer Network Guidelines in the rapidly evolving field of bladder cancer before working through challenging but common case scenarios that will outline important changes as well as concepts essential in providing evidence-based care.ACKNOWLEDGEMENTS:This educational activity is supported by an independent educational grants from:Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. | ||
| Non-Muscle Invasive Bladder Cancer: Expert Guidance for Advanced Practice Providers (2024) |
| 12/12/2024 | $0.00 | COMPLIMENTARY CME LIVE VIRTUAL COURSE!Join the AUA for Non-Muscle Invasive Bladder Cancer: Expert Guidance for Advanced Practice Providers (2024), featuring a dynamic live webinar tailored specifically for APPs. | |
| Non-Muscle Invasive Bladder Cancer: Expert Guidance for Advanced Practice Providers Webcast (2024) |
| $0.00 | COMPLIMENTARY CME WEBCAST! | ||
| Non-Muscle Invasive Bladder Cancer: Expert Guidance for Urologists - English (2024) |
| 12/19/2024 | $0.00 | COMPLIMENTARY CME LIVE VIRTUAL COURSE!Join the AUA for Non-Muscle Invasive Bladder Cancer: Expert Guidance for Urologists - English (2024), featuring a dynamic live webinar tailored specifically for Urologists and presented in English. | |
| Non-Muscle Invasive Bladder Cancer: Expert Guidance for Urologists Webcast - English (2024) |
| $0.00 | COMPLIMENTARY CME WEBCAST! | ||
| Oral Board Review Course (2025) | 02/22/2025 | $2,330.00 | Saturday Session- SOLD OUT*Sunday Session- SOLD OUT*If you would like to be added to the waitlist, please call 410-689-3917. |